A. Casanova

发表

Biology of Human Tumors RhoB Determines Tumor Aggressiveness in a Murine EGFRL 858 R-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer

G. Favre, I. Rouquette, T. Filleron, 2014 .

Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma.

J. Mazières, G. Favre, A. Pradines, 2016, Lung cancer.

Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1.

J. Mazières, G. Favre, B. Couderc, 2009, Cancer research.

Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma

J. Mazières, G. Favre, A. Pradines, 2017, Oncotarget.

Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy.

G. Favre, N. Meyer, Stéphanie Brayer, 2019, Acta dermato-venereologica.

The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors

G. Favre, O. Sordet, N. Meyer, 2015, Oncotarget.

RhoB Determines Tumor Aggressiveness in a Murine EGFRL858R-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer

J. Mazières, G. Favre, I. Rouquette, 2014, Clinical Cancer Research.

Phosphorylation of RhoB by CK1 impedes actin stress fiber organization and epidermal growth factor receptor stabilization.

B. Monsarrat, G. Favre, C. Froment, 2008, Experimental cell research.

Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.

M. Lacroix-Triki, G. Favre, A. Doncescu, 2016, Acta Dermato-Venereologica.

Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF-Mutated Lung Adenocarcinoma.

J. Soria, J. Mazières, G. Favre, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

RhoB Determines Tumor Aggressiveness in a Murine EGFRL858R-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer

J. Mazières, G. Favre, I. Rouquette, 2014, Clinical Cancer Research.

Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.

M. Lacroix-Triki, G. Favre, A. Doncescu, 2016, Acta dermato-venereologica.

Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies

J. Villemin, O. Calvayrac, A. Pradines, 2024, Nature communications.

Early Circulating Tumour DNA Variations Predict Tumour Response in Melanoma Patients Treated with Immunotherapy.

G. Favre, N. Meyer, Stéphanie Brayer, 2019, Acta dermato-venereologica.